Reverse Phase Protein Arrays (RPPA) represent a very promising sensitive and precise
high-throughput technology for the quantitative measurement of hundreds of signaling …

The ultimate goal of cancer biomarker discovery is to use individual patient-derived
biochemical information to improve patients' outcomes. A recent increase in the spectrum of …

Dedifferentiated liposarcoma (DDLS) is a rare but aggressive cancer with high recurrence
and low response rates to targeted therapies. Increasing treatment efficacy may require …

Because of their unknown long-term effects, repeated mild traumatic brain injuries (TBIs),
including the low, subconcussive ones, represent a specific challenge to healthcare …

Simple Summary Solid tumors account for~ 60% of pediatric, as well as adolescent and
young adult (AYA), cancers, and outcomes for patients with these progressive diseases …

Abstract Summary Reverse-Phase Protein Array (RPPA) is a robust high-throughput, cost-
effective platform for quantitatively measuring proteins in biological specimens. However …

Insulin and insulin-like growth factor I (IGF1) influence cancer risk and progression through
poorly understood mechanisms. To better understand the roles of insulin and IGF1 signaling …

Reverse-phase protein array (RPPA) technology uses panels of high-specificity antibodies
to measure proteins and protein post-translational modifications in cells and tissues. The …

Objective Patients who sustain acute Achilles tendon rupture (ATR) exhibit variable and
mostly impaired long-term functional, and patient-reported outcomes. However, there exists …

Multi-omics research has enhanced our understanding of cancer heterogeneity and
progression. Investigating molecular data through multi-omics approaches is crucial for …